心臓移植の市場規模、シェア、成長分析：タイプ別、エンドユーザー別、地域別 - 産業予測 2025～2032年

心臓移植の世界市場規模は2023年に116億米ドルと評価され、2024年の128億2,000万米ドルから2032年には284億9,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは10.5％で成長する見通しです。

世界の心臓移植市場は、末期心疾患の有病率の上昇に牽引され、重要な救命処置である心臓移植の需要を煽り、大きな成長を遂げています。手術手技、免疫抑制療法、臓器保存戦略における主要な技術進歩が市場拡大をさらに後押ししています。しかし、ドナー心臓の持続的な不足が大きな課題となっており、臓器調達方法の改善や移植基準の見直しの必要性が浮き彫りになっています。患者の転帰を向上させ、心臓移植を取り巻く複雑な問題に取り組むためには、医療界における継続的な研究イニシアチブと協力体制が不可欠です。市場が発展していく中で、これらの課題に取り組むことは、この重要な領域における持続可能な成長を促進し、全体的なヘルスケアソリューションを改善する上で極めて重要です。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制情勢
• ケーススタディ
• 技術の進歩

心臓移植市場規模：タイプ別& CAGR（2025-2032）

• 市場概要
• 補助人工心臓
• 人工心臓総数
• その他

心臓移植市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 病院
• 心臓病研究所
• その他

心臓移植市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Optum Inc.（USA）
• Novartis Pharmaceuticals UK Ltd.（UK）
• Abbott Laboratories（USA）
• Medtronic PLC（Ireland）
• Stryker Corporation（USA）
• Roche Diagnostics Ltd.（Switzerland）
• Mayo Clinic（USA）
• Cleveland Clinic（USA）
• AstraZeneca PLC（UK）
• Massachusetts General Hospital（USA）
• Terumo Corp.（Japan）
• NewYork-Presbyterian Hospital（USA）
• Cedars-Sinai Medical Center（USA）
• Maquet Holding B.V. and Co. KG.（Germany）
• Teleflex Inc.（USA）
• Stanford Health Care（USA）
• Johns Hopkins Hospital（USA）
• Thoratec Corporation（USA）
• Abiomed Inc.（USA）
• Baylor St. Luke's Medical Center（USA）

結論と推奨事項

Global Heart Transplant Market size was valued at USD 11.6 billion in 2023 and is poised to grow from USD 12.82 billion in 2024 to USD 28.49 billion by 2032, growing at a CAGR of 10.5% during the forecast period (2025-2032).

The global heart transplant market is experiencing significant growth, driven by the rising prevalence of end-stage heart diseases, which fuels demand for heart transplants as critical, life-saving procedures. Key technological advancements in surgical techniques, immunosuppressive therapies, and organ preservation strategies are further propelling market expansion. However, a persistent shortage of donor hearts poses a major challenge, highlighting the need for improved organ procurement methods and revised transplantation criteria. Ongoing research initiatives and collaborations within the medical community are essential for enhancing patient outcomes and tackling the complex issues surrounding heart transplantation. As the market evolves, addressing these challenges will be crucial for fostering sustainable growth and improving overall healthcare solutions in this critical domain.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Heart Transplant market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Heart Transplant Market Segmental Analysis

Global Heart Transplant Market is segmented by Type, End User and region. Based on Type, the market is segmented into Ventricular Assist Devices, Total Artificial Hearts and Others. Based on End User, the market is segmented into Hospitals, Cardiac Institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Heart Transplant Market

The Global Heart Transplant market is primarily driven by the rising demand for heart transplants, which is largely fueled by the escalating prevalence of end-stage heart diseases worldwide. This increasing need is complemented by significant advancements in surgical techniques, immunosuppressive therapies, and organ preservation methods, all of which enhance the feasibility and success rates of heart transplant procedures. As healthcare systems adapt to these innovations, the market continues to expand, responding to the urgent requirements of patients and improving overall outcomes in heart transplantation. These factors collectively contribute to the robust growth of the heart transplant sector on a global scale.

Restraints in the Global Heart Transplant Market

A significant constraint affecting the global heart transplant market is the ongoing and substantial shortage of donor organs, particularly viable hearts. This persistent deficiency severely restricts the number of transplant procedures that can be conducted. Additionally, the intricacies involved in the logistics of organ procurement, preservation, and transportation further complicate the process. The challenges associated with securing donor organs not only impact the availability for transplantation but also hinder advancements in surgical techniques and overall patient outcomes. This combination of limited supply and operational difficulties poses a major obstacle in meeting the growing demand for heart transplants.

Market Trends of the Global Heart Transplant Market

The Global Heart Transplant market is witnessing a significant shift towards advanced technologies, particularly genetic testing and regenerative medicine, enhancing organ viability and transplant outcomes. Innovations such as normothermic machine perfusion are improving the preservation of donor hearts, while stem cell therapies are being explored to reduce rejection risks. Additionally, the integration of telemedicine and remote monitoring solutions is transforming post-transplant care, ensuring continuous health management for patients. This trend reflects a broader commitment to optimizing heart transplant procedures and patient outcomes, ultimately expanding the market's growth potential and improving the quality of life for recipients.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Heart Transplant Market Size by Type & CAGR (2025-2032)

• Market Overview
• Ventricular Assist Devices
• Total Artificial Hearts
• Others

Global Heart Transplant Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Cardiac Institutes
• Others

Global Heart Transplant Market Size & CAGR (2025-2032)

• North America (Type, End User)
  • US
  • Canada
• Europe (Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Optum Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis Pharmaceuticals UK Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic PLC (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mayo Clinic (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cleveland Clinic (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Massachusetts General Hospital (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corp. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NewYork-Presbyterian Hospital (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cedars-Sinai Medical Center (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Maquet Holding B.V. and Co. KG. (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stanford Health Care (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johns Hopkins Hospital (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thoratec Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abiomed Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baylor St. Luke's Medical Center (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations